99 related articles for article (PubMed ID: 15334441)
1. Wegener's granulomatosis: Possible role of environmental agents in its pathogenesis.
Albert D; Clarkin C; Komoroski J; Brensinger CM; Berlin JA
Arthritis Rheum; 2004 Aug; 51(4):656-64. PubMed ID: 15334441
[TBL] [Abstract][Full Text] [Related]
2. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
[TBL] [Abstract][Full Text] [Related]
3. Occupational risk factors for Wegener's granulomatosis: a case-control study.
Knight A; Sandin S; Askling J
Ann Rheum Dis; 2010 Apr; 69(4):737-40. PubMed ID: 19364729
[TBL] [Abstract][Full Text] [Related]
4. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
[TBL] [Abstract][Full Text] [Related]
5. Cancer preceding Wegener's granulomatosis: a case-control study.
Faurschou M; Mellemkjaer L; Sorensen IJ; Thomsen BS; Dreyer L; Baslund B
Rheumatology (Oxford); 2009 Apr; 48(4):421-4. PubMed ID: 19213850
[TBL] [Abstract][Full Text] [Related]
6. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease.
Knight A; Sandin S; Askling J
Arthritis Rheum; 2008 Jan; 58(1):302-7. PubMed ID: 18163522
[TBL] [Abstract][Full Text] [Related]
7. Seasonal variations in onset of Wegener's granulomatosis: increased in summer?
Mahr A; Artigues N; Coste J; Aouba A; Pagnoux C; Guillevin L;
J Rheumatol; 2006 Aug; 33(8):1615-22. PubMed ID: 16832845
[TBL] [Abstract][Full Text] [Related]
8. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
9. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
[TBL] [Abstract][Full Text] [Related]
11. Are environmental factors important in primary systemic vasculitis? A case-control study.
Lane SE; Watts RA; Bentham G; Innes NJ; Scott DG
Arthritis Rheum; 2003 Mar; 48(3):814-23. PubMed ID: 12632437
[TBL] [Abstract][Full Text] [Related]
12. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; Limburg PC; Kallenberg CG
Arthritis Rheum; 2008 Jul; 58(7):2196-205. PubMed ID: 18576340
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?
Gatenby PA; Lucas RM; Engelsen O; Ponsonby AL; Clements M
Arthritis Rheum; 2009 Oct; 61(10):1417-24. PubMed ID: 19790114
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Wegener's granulomatosis: current concepts.
Sarraf P; Sneller MC
Expert Rev Mol Med; 2005 May; 7(8):1-19. PubMed ID: 15890083
[TBL] [Abstract][Full Text] [Related]
15. General and rhinosinusitis-related quality of life in patients with Wegener's granulomatosis.
Srouji IA; Andrews P; Edwards C; Lund VJ
Laryngoscope; 2006 Sep; 116(9):1621-5. PubMed ID: 16954992
[TBL] [Abstract][Full Text] [Related]
16. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
[TBL] [Abstract][Full Text] [Related]
18. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
[TBL] [Abstract][Full Text] [Related]
19. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
20. Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit.
Burkhardt O; Köhnlein T; Wrenger E; Lux A; Neumann KH; Welte T
Scand J Rheumatol; 2007; 36(2):119-24. PubMed ID: 17476618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
